Medicover
177.4
SEK
+0.45 %
MCOV B
NASDAQ Stockholm
Health Care Providers
Health Care
1 following
+0.45%
-4.52%
-4.42%
-6.34%
+18.19%
+19.3%
-35.61%
+76.69%
+170.84%
www.medicover.com/financial-information
Medicover is active in healthcare. The business activities are focused on service services within health care and diagnostics. The company offers primary and specialized care, financing solutions and laboratory tests in pathology. The main market is found around the European market with research institutes as the dominant customer base. Medicover was founded in 1995 and has its headquarters in Stockholm.
Revenue
19.44B
EBIT %
3.52 %
P/E
135.03
Dividend yield-%
0.75 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
MCOV B
Daily low / high price
176.6 / 179
SEK
Market cap
27.24B SEK
Turnover
1.78M SEK
Volume
10K
Latest videos
Financial calendar
Annual report
12.02.2025
Interim report
29.04.2025
General meeting
29.04.2025
Interim report
24.07.2025
Interim report
05.11.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Celox Holding AB | 30.7 % | 55.9 % |
Christina af Jochnick Family | 12.6 % | 22.4 % |
Fjärde AP-fonden | 9.3 % | 1.7 % |
Robert Af Jochnick | 9.0 % | 11.6 % |
AMF Aktier och Fonder | 2.5 % | 0.5 % |
Swedbank Robur Fonder | 2.0 % | 0.4 % |
Mertzig Equity Fund Sweden | 1.3 % | 0.2 % |
SEB Investment Management | 1.3 % | 0.2 % |
Vanguard | 1.2 % | 0.2 % |
ShowingAll content types
Medicover: Interim report July-September 2024
Invitation to Medicover's results presentation for Q3 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools